Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis
Clinical trial NCT02324972 · COMPLETED
Trial details
- NCT number
- NCT02324972
- Sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-11-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.